Cremecomtrsbi Dl 001 Stock Earnings Per Share
WY52 Stock | EUR 0.20 0.01 5.26% |
CREMECOMTRSBI DL 001 fundamentals help investors to digest information that contributes to CREMECOMTRSBI's financial success or failures. It also enables traders to predict the movement of CREMECOMTRSBI Stock. The fundamental analysis module provides a way to measure CREMECOMTRSBI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CREMECOMTRSBI stock.
CREMECOMTRSBI |
CREMECOMTRSBI DL 001 Company Earnings Per Share Analysis
CREMECOMTRSBI's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current CREMECOMTRSBI Earnings Per Share | (0.65) X |
Most of CREMECOMTRSBI's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CREMECOMTRSBI DL 001 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Competition |
According to the company disclosure, CREMECOMTRSBI DL 001 has an Earnings Per Share of -0.651 times. This is 151.26% lower than that of the Real Estate sector and significantly lower than that of the REIT—Office industry. The earnings per share for all Germany stocks is 120.87% higher than that of the company.
CREMECOMTRSBI Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CREMECOMTRSBI's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CREMECOMTRSBI could also be used in its relative valuation, which is a method of valuing CREMECOMTRSBI by comparing valuation metrics of similar companies.CREMECOMTRSBI is rated below average in earnings per share category among its peers.
CREMECOMTRSBI Fundamentals
Return On Equity | 0.014 | |||
Return On Asset | 0.0151 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.16 % | |||
Shares Outstanding | 22.74 M | |||
Shares Owned By Insiders | 13.49 % | |||
Shares Owned By Institutions | 59.07 % | |||
Price To Earning | 4.83 X | |||
Revenue | 101.34 M | |||
Gross Profit | 42.62 M | |||
EBITDA | 36.01 M | |||
Net Income | (30.95 M) | |||
Cash And Equivalents | 59.73 M | |||
Cash Per Share | 2.56 X | |||
Total Debt | 260.72 M | |||
Debt To Equity | 0.64 % | |||
Current Ratio | 7.28 X | |||
Book Value Per Share | 1.71 X | |||
Cash Flow From Operations | 25.43 M | |||
Earnings Per Share | (0.65) X | |||
Target Price | 13.0 | |||
Beta | 0.54 | |||
Market Capitalization | 115.29 M | |||
Annual Yield | 0.07 % | |||
Five Year Return | 3.73 % | |||
Last Dividend Paid | 0.33 |
About CREMECOMTRSBI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CREMECOMTRSBI DL 001's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CREMECOMTRSBI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CREMECOMTRSBI DL 001 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CREMECOMTRSBI Stock
CREMECOMTRSBI financial ratios help investors to determine whether CREMECOMTRSBI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREMECOMTRSBI with respect to the benefits of owning CREMECOMTRSBI security.